2012 Meter Change
Impact Of 2012 Diabetes Meter Change
In 2012 PHARMAC made a funding decision that meant more than 100,000 people needed to change their blood glucose meters and test strips.
PHARMAC commissioned two reports looking into the change which were submitted in August 2015:
1. An evaluation of the clinical impacts of the decision
- The report shows that it is unlikely there was anything wrong with the three CareSens meters. A match group of new meter users before and after the change showed no difference in hospitalisations over their first five months (228 in 2011, and 186 in 2014).
- It is possible that there were clinical impacts. Well before the change to the meters there were increasing rates of people with diabetes being hospitalised. This trend continued throughout the change and declined afterwards. Whether this decrease was a result of the meter change or other changes in the health system, disease, or treatment, is unknown.
- Overall the report confirms that change in the health sector can have an impact on patient health. We want to maximise the beneficial impacts and minimise actions which have negative consequences. PHARMAC recognises that it has to be very careful when making change
2. An evaluation of the implementation of the decision
- Inclusion of key questions as part of the consultation process so that it is clear what the consultation is seeking responses to.
- Regularly include face-to-face meetings with key stakeholders as part of consultation for major changes.
- Identify wider health sector impacts with major changes, and work closely with other agencies, where possible, to help make referral pathways and support easier for people to access.
- Take more time to identify what may be the key consumer concerns and provide messaging to health professionals to support and reassure people with changes.
Strategic Refresh of the Health Research Council
This report, written by officials from the Ministry of Health and the Ministry of Business, Innovation and Employment, recommends improving the strategic alignment of those who have a stake in health research and innovation in New Zealand. The primary vehicle proposed for achieving this is the development of a health research strategy.
Science and Innovation Minister Steven Joyce and Health Minister Jonathan Coleman announced on 10 November 2015 that a new health research strategy will be developed and public consultation is expected to begin in early 2016.
Read the Health Research Council Report.